News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Roche Genentech Releases Letter to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD

Blog Post

MDA Care Centers Combine Expert Care with Research, Clinical Trials, and Advanced Technology

MDA logo
Blog Post

AveXis Releases Letter to SMA Community: FDA Places Partial Hold on Clinical Trials for Intrathecally Delivered AVXS-101

Blog Post

World Muscle Society Roundup: Clinical Trial Results of Treatments in Development for DMD, XLMTM, SMA, and Pompe Disease

Blog Post

Reata Pharmaceuticals Announces Positive Results from Pivotal Study of Omaveloxolone in FA

Blog Post

Capricor Therapeutics Announces Positive Interim Results from Phase 2 Study of CAP-1002 to Treat DMD

Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

Blog Post

Casey’s General Stores Round Up for MDA